Heartflow vs iRhythm
HTFL and IRTC side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How HTFL and IRTC compare
Heartflow is the larger company, worth 1.8 times as much as iRhythm ($5.1B against $2.9B).
Heartflow grew revenue faster over the last twelve months (42.8% versus 21.6% for iRhythm).
iRhythm keeps more of each dollar of sales as profit, with a net margin of −4.5% compared with −55.8% at Heartflow.
iRhythm scores higher on the StockData Score (9 against 5 for Heartflow), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | HTFL | IRTC |
|---|---|---|
| Size and price | ||
| Market cap | $5.1B | $2.9B |
| Share price | $59.10 | $88.68 |
| Change, 1 year | 74.7% | −49.7% |
| Change, 5 years | – | −11.5% |
| Beta (5Y) | 1.96 | 1.20 |
| Employees | 843 | 2,400 |
| StockData Score | ||
| Total score | 5 | 9 (better) |
| Valuation score | 0 | 1 (better) |
| Growth score | 3 | 4 (better) |
| Performance score | 0 | 3 (better) |
| Health score | 2 (better) | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 24.2× | 3.4× (better) |
| P/B | 18.4× | 16.5× (better) |
| P/FCF | – | 396× |
| FCF yield | −1.2% | 0.25% (better) |
| Fair value | $8.61 | $94.07 |
| Margin of safety | −586% | 5.7% (better) |
| Growth | ||
| Revenue growth (TTM) | 42.8% (better) | 21.6% |
| Revenue growth, 5Y average | – | 23.0% |
| Profitability | ||
| Gross margin | 80.1% (better) | 72.3% |
| Operating margin | −37.8% | −5.7% (better) |
| Net margin | −55.8% | −4.5% (better) |
| FCF margin | −27.9% | 0.86% (better) |
| Return on equity | – | −25.8% |
| Financial health | ||
| Interest coverage | −23.2× | −3.7× (better) |
| Current ratio | 5.08 (better) | 3.57 |
| Altman Z-score | 43.51 (better) | 2.04 |
| Piotroski F-score | 6 (better) | 5 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 86.0% | 108% |
| Held by insiders | 58.7% | 2.1% |
| Insider net buying, 12 months | −$143M | −$24.4M (better) |
| Short interest, % of float | 15.9% | 10.1% |
Go deeper
- HTFL stock overview
- HTFL income statement
- HTFL valuation and score
- IRTC stock overview
- IRTC income statement
- IRTC valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.